Renaissance Technologies’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Sell |
58,800
-5,800
| -9% | -$24.7K | ﹤0.01% | 3093 |
|
|
2025
Q1 | $243K | Sell |
64,600
-92,700
| -59% | -$349K | ﹤0.01% | 3002 |
|
|
2024
Q4 | $917K | Buy |
157,300
+127,900
| +435% | +$746K | ﹤0.01% | 2544 |
|
|
2024
Q3 | $351K | Sell |
29,400
-23,800
| -45% | -$284K | ﹤0.01% | 2921 |
|
|
2024
Q2 | $576K | Buy |
+53,200
| New | +$576K | ﹤0.01% | 2627 |
|
|
2024
Q1 | – | Sell |
-173,611
| Closed | -$2.44M | – | 3964 |
|
|
2023
Q4 | $2.44M | Sell |
173,611
-136,889
| -44% | -$1.92M | ﹤0.01% | 1832 |
|
|
2023
Q3 | $3.84M | Buy |
310,500
+17,600
| +6% | +$217K | 0.01% | 1453 |
|
|
2023
Q2 | $2.65M | Buy |
292,900
+35,700
| +14% | +$322K | ﹤0.01% | 1821 |
|
|
2023
Q1 | $892K | Sell |
257,200
-9,000
| -3% | -$31.2K | ﹤0.01% | 2550 |
|
|
2022
Q4 | $652K | Sell |
266,200
-114,300
| -30% | -$280K | ﹤0.01% | 2787 |
|
|
2022
Q3 | $1.05M | Buy |
380,500
+94,366
| +33% | +$260K | ﹤0.01% | 2469 |
|
|
2022
Q2 | $1.17M | Buy |
286,134
+38,802
| +16% | +$158K | ﹤0.01% | 2608 |
|
|
2022
Q1 | $1.05M | Buy |
+247,332
| New | +$1.05M | ﹤0.01% | 2692 |
|
|
2021
Q4 | – | Sell |
-97,900
| Closed | -$2.7M | – | 4134 |
|
|
2021
Q3 | $2.7M | Buy |
+97,900
| New | +$2.7M | ﹤0.01% | 1870 |
|